1. (1) A manufacturer, health care provider, or health care facility may make an experimental treatment available upon a patient's request.

2. (2) The manufacturer, health care provider, or health care facility may:

   1. (a) provide an experimental treatment to a patient without receiving compensation; or
   2. (b) establish payment arrangements with a patient for an experimental treatment.
3. (3) A manufacturer, health care provider, or health care facility is not required to make an experimental treatment available to a patient.

History: En. Sec. 3, Ch. 135, L. 2015; amd. Sec. 2, Ch. 413, L. 2023; amd. Sec. 7, Ch. 621, L. 2025.